FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2071033172> ?p ?o ?g. }

• W2071033172 endingPage "505" @default.
• W2071033172 startingPage "495" @default.
• W2071033172 abstract "In breast cancer there is often overexpression of the breast cancer antigen CA15-3, the carcinoembryonic antigen (CEA) and the ovarian cancer antigen CA125, which makes them potential target antigens for immunotherapy. In this study, we used a multi-antigen vaccine, which included the following antigens: autologous breast cancer cells (AUTOC), allogeneic breast cancer MCF-7 cells (ALLOC), and the tumor associated antigens CA15-3, CEA and CA125, plus low doses of granulocyte/macrophage-colony-stimulating factor (GM-CSF) and interleukin 2 (IL-2). Forty-two breast cancer patients received weekly subcutaneous vaccination at the 1st, 2nd, 3rd, 7th, 11th and 15th weeks. Their lymphocyte proliferative responses to AUTOC, ALLOC, CA15-3, CEA and CA125 were tested in lymphocyte blastogenesis assays (LBA) before and after vaccination. The disease stage and serum CA15-3, CEA and CA125 concentrations were also determined pre- and post-vaccination. We found that the vaccine was safe, and the only major side effects were swelling at the site of injection, muscle pain, and weakness or fatigue. The vaccine induced a significant increase in post-vaccination lymphocyte proliferative responses to AUTOC, CA15-3, CEA and CA125 but not ALLOC, compared to pre-vaccination (p < 0.05, p < 0.01, p < 0.05, p < 0.01 and p > 0.05, respectively, a paired t Test). Computed tomography (CT), ultrasound or bone scan showed evidence of disease improvement in 2 (12%) patients after vaccination. Hepatic metastases were reduced in size and number and some actually disappeared one patient. Metastatic disease in the L5 vertebra and the skull decreased in size and some osteolytic sites completely healed in a second patient. In addition, 7 patients (44%) had stable disease and 7 patients (44%) had disease progression. We did not find vaccination significantly reduced serum tumor markers CA15-3, CEA and CA125 of these breast cancer patients. These results suggest that the vaccine mixture of autologous and allogeneic breast cancer cells and tumor associated antigens plus GM-CSF and IL-2 can be administered safely to breast cancer patients and there is evidence for improved immunity and clinical efficacy." @default.
• W2071033172 created "2016-06-24" @default.
• W2071033172 creator A5014572120 @default.
• W2071033172 creator A5040438084 @default.
• W2071033172 creator A5071731677 @default.
• W2071033172 creator A5073054489 @default.
• W2071033172 date "2000-10-01" @default.
• W2071033172 modified "2023-09-26" @default.
• W2071033172 title "Vaccination with a Mixed Vaccine of Autogenous and Allogeneic Breast Cancer Cells and Tumor Associated Antigens CA15-3, CEA and CA125 - Results in Immune and Clinical Responses in Breast Cancer Patients" @default.
• W2071033172 cites W1445322489 @default.
• W2071033172 cites W1965781424 @default.
• W2071033172 cites W1971107219 @default.
• W2071033172 cites W1972464496 @default.
• W2071033172 cites W1994405616 @default.
• W2071033172 cites W2013082284 @default.
• W2071033172 cites W2016203595 @default.
• W2071033172 cites W2016832628 @default.
• W2071033172 cites W2017229120 @default.
• W2071033172 cites W2022521773 @default.
• W2071033172 cites W2029910544 @default.
• W2071033172 cites W2038955778 @default.
• W2071033172 cites W2053853693 @default.
• W2071033172 cites W2059483129 @default.
• W2071033172 cites W2086623826 @default.
• W2071033172 cites W2090119280 @default.
• W2071033172 cites W2092312916 @default.
• W2071033172 cites W2163420537 @default.
• W2071033172 cites W2320692446 @default.
• W2071033172 cites W2343242752 @default.
• W2071033172 cites W2464475459 @default.
• W2071033172 cites W2610325278 @default.
• W2071033172 cites W4211204392 @default.
• W2071033172 doi "https://doi.org/10.1089/cbr.2000.15.495" @default.
• W2071033172 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11155821" @default.
• W2071033172 hasPublicationYear "2000" @default.
• W2071033172 type Work @default.
• W2071033172 sameAs 2071033172 @default.
• W2071033172 citedByCount "43" @default.
• W2071033172 countsByYear W20710331722012 @default.
• W2071033172 countsByYear W20710331722013 @default.
• W2071033172 countsByYear W20710331722014 @default.
• W2071033172 countsByYear W20710331722017 @default.
• W2071033172 countsByYear W20710331722018 @default.
• W2071033172 countsByYear W20710331722019 @default.
• W2071033172 countsByYear W20710331722020 @default.
• W2071033172 countsByYear W20710331722021 @default.
• W2071033172 countsByYear W20710331722022 @default.
• W2071033172 countsByYear W20710331722023 @default.
• W2071033172 crossrefType "journal-article" @default.
• W2071033172 hasAuthorship W2071033172A5014572120 @default.
• W2071033172 hasAuthorship W2071033172A5040438084 @default.
• W2071033172 hasAuthorship W2071033172A5071731677 @default.
• W2071033172 hasAuthorship W2071033172A5073054489 @default.
• W2071033172 hasConcept C118646709 @default.
• W2071033172 hasConcept C121608353 @default.
• W2071033172 hasConcept C126322002 @default.
• W2071033172 hasConcept C143998085 @default.
• W2071033172 hasConcept C147483822 @default.
• W2071033172 hasConcept C203014093 @default.
• W2071033172 hasConcept C22070199 @default.
• W2071033172 hasConcept C2776624504 @default.
• W2071033172 hasConcept C2777387746 @default.
• W2071033172 hasConcept C2777701055 @default.
• W2071033172 hasConcept C530470458 @default.
• W2071033172 hasConcept C71924100 @default.
• W2071033172 hasConcept C8891405 @default.
• W2071033172 hasConceptScore W2071033172C118646709 @default.
• W2071033172 hasConceptScore W2071033172C121608353 @default.
• W2071033172 hasConceptScore W2071033172C126322002 @default.
• W2071033172 hasConceptScore W2071033172C143998085 @default.
• W2071033172 hasConceptScore W2071033172C147483822 @default.
• W2071033172 hasConceptScore W2071033172C203014093 @default.
• W2071033172 hasConceptScore W2071033172C22070199 @default.
• W2071033172 hasConceptScore W2071033172C2776624504 @default.
• W2071033172 hasConceptScore W2071033172C2777387746 @default.
• W2071033172 hasConceptScore W2071033172C2777701055 @default.
• W2071033172 hasConceptScore W2071033172C530470458 @default.
• W2071033172 hasConceptScore W2071033172C71924100 @default.
• W2071033172 hasConceptScore W2071033172C8891405 @default.
• W2071033172 hasIssue "5" @default.
• W2071033172 hasLocation W20710331721 @default.
• W2071033172 hasLocation W20710331722 @default.
• W2071033172 hasOpenAccess W2071033172 @default.
• W2071033172 hasPrimaryLocation W20710331721 @default.
• W2071033172 hasRelatedWork W1863700672 @default.
• W2071033172 hasRelatedWork W1996150995 @default.
• W2071033172 hasRelatedWork W2118125095 @default.
• W2071033172 hasRelatedWork W2220102944 @default.
• W2071033172 hasRelatedWork W2224319365 @default.
• W2071033172 hasRelatedWork W2409441623 @default.
• W2071033172 hasRelatedWork W2513966554 @default.
• W2071033172 hasRelatedWork W3029946366 @default.
• W2071033172 hasRelatedWork W4210976760 @default.
• W2071033172 hasRelatedWork W4360983034 @default.
• W2071033172 hasVolume "15" @default.
• W2071033172 isParatext "false" @default.
• W2071033172 isRetracted "false" @default.
• W2071033172 magId "2071033172" @default.

• next